首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1397166

全球 IVF 市場：洞察、競爭格局、市場預測：2028 年

In Vitro Fertilization - Market Insights, Competitive Landscape, and Market Forecast - 2028

出版日期: 2023年12月18日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 1-3個工作天內

價格

簡介目錄圖表

預計 2023 年至 2028 年預測期內，全球 IVF 市場規模將以 6.31% 的複合年增長率擴大。對體外受精的需求主要是由於男性和女性不孕症病例數量的增加、懷孕延遲、性健康問題、體外受精技術成功率的提高、肥胖率的增加、先進和擴大的不孕症的引入推動了體外受精的需求2023年至2028年，體外受精治療，即胞漿內單一精子注射（ICSI）、產品上市和批准增加、產品開發創新等，促進了預測期內IVF市場的整體成長。

由於全球範圍內不孕症及其風險因素的盛行率不斷上升，整個 IVF 市場預計將擴大。不孕症影響著世界各地很大一部分的夫婦，而懷孕的願望正在推動對不孕症相關產品和服務的需求。根據經濟合作暨發展組織（OECD）2023年發布的數據，韓國、法國、瑞典和瑞士2021年的總生育率（TFR）分別為0.81、1.80、1.67和1.51，低於平均TFR 為2.1。我是。

根據世界衛生組織 (WHO) 的估計，到 2023 年，全球大約六分之一的育齡人口在一生中會經歷不孕不育的情況。世界不同地區不孕率的增加將增加預測期內對體外受精（IVF）的需求。

然而，假陽性結果、保險覆蓋率低以及新興市場缺乏保險預計將限制整個 IVF 市場的成長。

本報告檢視了全球 IVF 市場，並提供了市場概述，包括按產品、最終用戶、地區劃分的趨勢以及進入市場的公司概況。

In Vitro Fertilization Market By Product (Instrument [Imaging Systems, Incubators, Cryosystems, Ivf Cabinet, Sperm Separation Devices, Ovum Aspiration Pump, And Others] And Reagent), End-User (Hospitals, Fertility Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing cases of infertility and delay in pregnancies.

The global in vitro fertilization market is estimated to grow at a CAGR of 6.31% during the forecast period from 2023 to 2028. The demand for in vitro fertilization is primarily being boosted by the increasing cases of infertility among both men and women, delayed onset of pregnancies, issues pertaining to sexual health, rising success rate of IVF technology, the growing obesity rate, introduction of advanced and extended fertility treatment of IVF i.e. intracytoplasmic sperm injection (ICSI), increasing product launches and approvals, and innovation in product development among others, thereby contribute to the overall growth of the in vitro fertilization market during the forecast period from 2023-2028.

In Vitro Fertilization Market Dynamics:

The rising prevalence of infertility and its risk factors across the globe will increase the overall market of in vitro fertilization. Infertility affects a significant percentage of couples worldwide, and the desire to conceive has fueled the demand for fertility-related products and services. The data published by the Organization for Economic Co-operation and Development (OECD) 2023 says that in 2021 the total fertility rate (TFR) in Korea, France, Sweden, and Switzerland was 0.81, 1.80, 1.67, and 1.51 respectively which is less than average TFR of 2.1.

As per the above-mentioned source, the TFR for most of the countries in 2020 was below the average TFR with Australia having a TFR of 1.58, Canada at 1.50, China at 1.70, the United States at 1.64, the United Kingdom at 1.56, Spain 1.36, Japan 1.33, and South Korea with 0.84 TFR.

The World Health Organization (WHO) 2023 estimates suggest that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.

According to World Bank 2022, the total fertility rate (TFR) in most of the regions including North and South America to Europe and Asia-Pacific was 1.6 in 2020 which is comparatively lower than the average TFR of 2.1.

The increasing infertility among the different regions across the globe will increase the demand for in vitro fertilization (IVF) during the forecast period.

In addition, there's a rising push by the government and other groups to start several public education programs regarding reproductive health, available treatments, and the causes of infertility problems. For example, Pinnacle Fertility started the Save IVF campaign in August 2022 to raise awareness about possible new laws that could endanger family-building procedures. In honor of World IVF Day, Oasis Fertility also started the Infertility Knows No Gender campaign in July 2022. Millions of infertile couples have a glimmer of hope because of in vitro fertilization (IVF).

Furthermore, the increasing launches of IVF facilities and new technologies across the globe for providing better services are also contributing to segment growth. For instance, in August 2022, the Rejuvenating Fertility Center (RFC) launched Injection-Free IVF or Needle-Free IVF procedures. This non-conventional holistic treatment uses oral and nasal fertility drugs to stimulate the patient's ovaries during in vitro fertilization (IVF). This gently stimulates the ovaries to produce multiple higher-quality eggs. Such developments are expected to increase the demand for needleless IVF treatment.

Therefore, the above-mentioned factors will propel the in vitro fertilization market during the forecast period from 2023-2028.

However, false positive results, low coverage, or absence of insurance in the emerging market, and others may restrict the growth of the overall in vitro fertilization market.

In Vitro Fertilization Market Segment Analysis:

In Vitro Fertilization Market by Product (Instrument [Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Sperm Separation Devices, Ovum Aspiration Pump, and Others] and Reagent), End-User (Hospitals, Fertility Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the in vitro fertilization market, the sperm separation devices category is expected to amass a significant revenue share in the year 2022. This can be ascribed to the advantages and applications associated with the segment.

In most assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and artificial insemination, sperm separation systems are used. These systems are critical for assisted reproductive technologies (ARTs) because they provide purified samples that can be used in subsequent procedures. These systems are crucial for ARTs as they provide purified samples for further procedures.

The market is predicted to rise as a result of the growing usage of cutting-edge technologies, such as sperm syringes, in the process of choosing high-quality sperm. With a sperm syringe, a highly parallelized and quick sorting mechanism is made possible by providing the maximal contact area between 1.5 ml of the semen sample and selection events. This retrieval efficiency allows for more frequent avoidance of the more invasive intracytoplasmic sperm injection (ICSI) method by providing a sufficient volume and number of high-quality sperm for droplet-based IVF and intrauterine insemination (IUI). Additionally, compared to intracytoplasmic sperm injection, sperm syringes provide clinics with a viable alternative for implementing less invasive assisted reproductive technologies (ARTs), hence minimizing the associated clinical strain and enhancing the long-term health outcomes for ART-conceived infants.

Therefore, owing to the above-mentioned factors, the sperm separation devices category is expected to register significant growth, thereby driving the growth of the overall in vitro fertilization market during the forecast period.

North America is expected to dominate the overall In Vitro Fertilization Market:

Among all the regions, North America is estimated to account for the largest share of the In Vitro Fertilization market in the year 2022. Owing to the significance of key growth factors such as the rising prevalence of associated conditions such as polycystic ovary syndrome (PCOS), standardization of procedures, government funding for sperm and egg storage, a constant rise in the incidence of infertility in both sexes, the presence of various leading players in this region, the growing number of single women and same-sex couples, and favorable regulatory reforms, presence of key players, increasing product development activities, and others, the market for in vitro fertilization is expected to witness prosperity in the region during the forecast period 2022-2028.

As per the data provided by the Centers for Disease Control and Prevention (CDC) 2023, in the United States, among married women aged 15 to 49 years with no prior births, about 1 in 5 (19%) are unable to get pregnant after one year of trying (infertility). Also, about 1 in 4 (26%) women have difficulty getting pregnant or carrying a pregnancy to term (impaired fecundity). Also, infertility and impaired fecundity are less common among women with one or more prior births. About 6% of married women aged 15 to 49 years are unable to get pregnant after one year of trying and 14% have difficulty getting pregnant or carrying a pregnancy to term.

Canada is a low-fertility country or below the no-migration population replacement level of 2.1 children per woman. As per Statistics Canada 2022, the country's fertility rate decreased from 1.47 children per woman in 2019 to a record low of 1.40 children per woman in 2020.

The World Population Data Sheet 2022, stated that in 2022, the fertility rate in Mexico was 1.8 children per woman.

As per the OECD datasheet 2020, it was estimated that by 2050, the fertility rate in Mexico will amount to 1.72 children per woman.

Thus, from the above sources it can be concluded that the prevalence of infertility is increasing in different countries within the North American region.

The increasing adoption of various business strategies such as acquisitions, partnerships, and others by the companies increases the introduction of advanced fertility treatment centers and options, which is anticipated to propel market growth. For instance, in December 2021, Cooper Companies acquired Generate Life Sciences, a provider of donor eggs and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage (cord blood and cord tissue) for approximately USD 1.6 billion. With this acquisition, CooperSurgical can offer fertility clinics, Obstetrics, and Gynaecology even stronger services and products.

Thus, the above-mentioned factors are likely to propel the growth of the in vitro fertilization market in the region during the forecast period from 2023-2028.

In Vitro Fertilization Market Key Players:

Some of the key market players operating in the in vitro fertilization market include: CooperSurgical, Inc., Cook Medical, FUJIFILM Holdings America Corporation, Genea Biomedx, Hamilton Thorne, Merck KGaA, SRL Diagnostic, Nikon Instruments Inc., Thermo Fisher Scientific Inc., Vitrolife, Sysmex Corporation, Rocket Medical plc., Menicon Co. Ltd., LensHooke, Promega Corporation, and others.

Recent Developmental Activities in the In Vitro Fertilization Market:

In May 2023, AIVF, the developer of AI-based solutions for IVF clinics, and Genea Biomedx launched an integrated system. The new integrated solution provides widespread access to individualized, improved IVF care by connecting Genea Biomedx's Geri time-lapse incubator with AIVF's innovative EMA AI platform.
In December 2022, Kindbody launched a state-of-the-art clinic and in vitro fertilization (IVF) lab in Dallas to meet the increasing demand for world-class fertility care and comprehensive family-building benefits by patients and employers in the area.
In March 2022, Malta, in collaboration with Pera Labs's commercialization advisors at the University City Science Center, started the research and development of an AI-powered sperm and egg selection technology for fertility treatments. Pera Labs's Malta operations are accelerated by the EUR 800,000 (USD 8,83,040) of financial support from Malta Enterprise, coupled with Pera Labs's financing.

Key Takeaways from the In Vitro Fertilization Market Report Study:

Market size analysis for current in vitro fertilization market size (2022), and market forecast for 5 years (2023-2028)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global in vitro fertilization market.
Various opportunities available for the other competitors in the in vitro fertilization market space.
What are the top-performing segments in 2022? How these segments will perform in 2028?
Which are the top-performing regions and countries in the current in vitro fertilization market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for in vitro fertilization market growth in the coming future?

Target Audience who can be benefited from this In Vitro Fertilization Market Report Study:

In Vitro Fertilization product providers
Research organizations and consulting companies
In Vitro Fertilization-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in In Vitro Fertilization
Various End-users who want to know more about the in vitro fertilization market and the latest technological developments in the in vitro fertilization market.

Frequently Asked Questions for the In Vitro Fertilization Market:

1. What is in vitro fertilization?

In vitro fertilization is an assistive reproductive technology that involves the process of fertilization by retrieving eggs from the woman's ovaries and fertilizing them with sperm outside of the body in a laboratory environment.

2. What is the market for global in vitro fertilization?

The global in vitro fertilization market is estimated to grow at a CAGR of 6.31% during the forecast period from 2023 to 2028.

3. What are the drivers for the global in vitro fertilization market?

The demand for in vitro fertilization is primarily being boosted by the increasing prevalence of infertility, increasing success rate of IVF procedures, increasing awareness about infertility the introduction of advanced and extended fertility treatment of IVF, delay in pregnancies, increasing product launches and approvals, and others thereby contributing to the overall growth of the in vitro fertilization market during the forecast period from 2023-2028.

4. Who are the key players operating in the global in vitro fertilization market?

Some of the key market players operating in the in vitro fertilization market include CooperSurgical, Inc., Cook Medical, FUJIFILM Holdings America Corporation, Genea Biomedx, Hamilton Thorne, Merck KGaA, SRL Diagnostic, Nikon Instruments Inc., Thermo Fisher Scientific Inc., Vitrolife, Sysmex Corporation, Rocket Medical plc., Menicon Co. Ltd., LensHooke, Promega Corporation, and others.

5. Which region has the highest share in the in vitro fertilization market?

North America is expected to dominate the overall in vitro fertilization market during the forecast period from 2023-2028. Owing to factors such as increasing cases of male & female infertility, rising prevalence of associated conditions such as polycystic ovary syndrome (PCOS), standardization of procedures, government funding for sperm and egg storage, presence of various leading players in this region, the growing number of single women and same-sex couples among others, favorable regulatory reforms, among other North America in vitro fertilization market is expected to growth in coming years.

1. In Vitro Fertilization Market Report Introduction

2. In Vitro Fertilization Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. In Vitro Fertilization Market Key Factors Analysis

4.1. In Vitro Fertilization Market Drivers
- 4.1.1. Increasing cases of infertility among both men and women
- 4.1.2. Delayed onset of pregnancies
- 4.1.3. Rising success rate of IVF technology
4.2. In Vitro Fertilization Market Restraints and Challenges
- 4.2.1. Complications Associated with In Vitro Fertilization
- 4.2.2. Social stigma, ethical, and legal issues associated with in vitro fertilization
4.3. In Vitro Fertilization Market Opportunities
- 4.3.1. Artificial intelligence and machine learning making their way into the world of IVF
- 4.3.2. Increasing demand for ovarian tissue cryopreservation technology

5. In Vitro Fertilization Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. In Vitro Fertilization Market Layout

6.1. By Product
- 6.1.1. Instrument
  - 6.1.1.1. Imaging systems
  - 6.1.1.2. Incubators
  - 6.1.1.3. Cryosystems
  - 6.1.1.4. IVF Cabinet
  - 6.1.1.5. Sperm Separation Devices
  - 6.1.1.6. Ovum Aspiration Pump
  - 6.1.1.7. Others
- 6.1.2. Reagent
6.2. By End-User
- 6.2.1. Hospitals
- 6.2.2. Fertility Clinics
- 6.2.3. Others
6.3. By Geography
- 6.3.1. North America In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.1.1. United States In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.1.2. Canada In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.1.3. Mexico In Vitro Fertilization Market Size in USD million (2020-2028)
- 6.3.2. Europe In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.2.1. France In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.2.2. Germany In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.2.3. United Kingdom In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.2.4. Italy In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.2.5. Spain In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.2.6. Rest of Europe In Vitro Fertilization Market Size in USD million (2020-2028)
- 6.3.3. Asia-Pacific In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.3.1. China In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.3.2. Japan In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.3.3. India In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.3.4. Australia In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.3.5. South Korea In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.3.6. Rest of Asia-Pacific In Vitro Fertilization Market Size in USD million (2020-2028)
- 6.3.4. Rest of the World (RoW) In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.4.1. Middle East In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.4.2. Africa In Vitro Fertilization Market Size in USD million (2020-2028)
  - 6.3.4.3. South America In Vitro Fertilization Market Size in USD million (2020-2028)

7. In Vitro Fertilization Market Company and Product Profiles

7.1. CooperSurgical, Inc.
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Cook Medical
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. FUJIFILM Holdings America Corporation
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. Genea Biomedx
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. Hamilton Thorne
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. Merck KGaA
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. SRL Diagnostic
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. Nikon Instruments Inc.
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. Thermo Fisher Scientific Inc.
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. Vitrolife
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. Sysmex Corporation
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. Rocket Medical plc.
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13. Menicon Co. Ltd.
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14. LensHooke
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
7.15. Promega Corporation
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy